Data | Non septic SIRS (n = 11) | Sepsis (n = 5) | P value |
---|---|---|---|
Male/female | 8/3 | 5/0 | 0.55 |
Age (years) | 69 ± 10 | 61 ± 24 | 0.37 |
ASA physical status (III/IV) | 7/4 | 2/3 | 0.72 |
Length of stay in the ICU (days) | 5 (3-6) | 14 (8-18) | 0.26 |
SAPS II | 34 (27-42) | 23 (19-50) | 0.76 |
EuroSCORE | 9 ± 4 | 8 ± 1 | 0.67 |
LVEF <50% | 3 (27%) | 2 (40%) | 0.95 |
Baseline biologic measurements | Â | Â | Â |
- WBC (G/L) | 7.6 ± 2.4 | 6.9 ± 1.0 | 0.59 |
- CRP (mg/L) | 6.4 (2.4-11.1) | 10.9 (1.7-18.3) | 0.96 |
- PCT (ng/L) | 0.09 (0.08-0.18) | 0.09 (0.07-0.20) | 1 |
- BPW (%T/s) | 0.02 ± 0.02 | 0.04 ± 0.03 | 0.27 |
Surgical procedure (n) | Â | Â | Â |
- Valvular surgery | 7 (63%) | 3 (60%) | Â |
- Combined surgery | 2 (18%) | 1 (20%) | Â |
- Ascending aorta surgery | 2 (18%) | 1 (20%) | Â |
- CABG | 0 | 0 | Â |
CPB duration (min) | 118 (90-120) | 139 (103-208) | 0.31 |
Aortic cross clamping time (min) | 84 ± 27 | 99 ± 39 | 0.39 |
Post operative complications (n) | Â | Â | Â |
- Reoperation | 1 (9%) | 3 (60%) | 0.12 |
- Hemorrhage | 2 (18%) | 3 (60%) | 0.27 |
- Tamponade | 0 | 2 (40%) | 0.15 |
- Inotropic support | 3 (27%) | 2 (40%) | 0.95 |
- Myocardial infarction | 0 | 1 (20%) | 0.68 |
- AKI requiring RRT | 1 (9%) | 2 (40%) | 0.43 |
Death (n) | 2 (18%) | 2 (40%) | 0.75 |